Measurement
BLOOD
Blood tests were carried out at the baseline and at week 4 (referring to the last observation day, 4 weeks after the intervention) to measure blood glucose and HbA1c. BMI and body composition were measured using Inbody 720 (InBody Co., Ltd., Seoul, Korea), a non‐invasive body composition analyzer, at the baseline and at week 4. Other than body fat percentage (total fat mass / body weight [%]) and ASM (kg), weight‐adjusted ASM (ASM / bodyweight [%]) and height‐adjusted ASM (ASM / height